Some sectors are holding up much better than others in the current market environment – and offering compelling plays in the process. One of those sectors is biotech where, today’s article notes, “the pros say there are names that have not only received a lot of love from the analyst community, but also stand to deliver hefty returns through 2020 and beyond.” For three biotech stocks that have garnered “Strong Buy” analyst ratings and that have plenty of upside potential based on analyst price targets, CLICK HERE.